Jump to content

2019 CSCO| CStone announces promising ORR, anti-tumor activity and safety data with its anti-PD-L1 antibody CS1001 in MSI-H/dMMR solid tumors


In The News

Recommended Posts

Archived

This topic is now archived and is closed to further replies.



×
×
  • Create New...